TTYH3 and testicular cancer: In the GENT database, analyzed using the U133Plus2 platform, TTYH3 expression was upregulated in certain cancer types, including bladder, breast, colon, lung, pancreatic, stomach, ovarian, and testicular cancers (Figure 1c).